Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism.
暂无分享,去创建一个
M. Welch | C. Anderson | K. Zinn | W. B. Edwards | B. Rogers | L. Guo | J. Connett | Eliot Sherman | L. W. Guo | Elizabeth L. C. Sherman
[1] David E Reichert,et al. Stability and Structure of Activated Macrocycles. Ligands with Biological Applications. , 1996, Inorganic chemistry.
[2] M. Welch,et al. In vitro and in vivo evaluation of copper-64-octreotide conjugates. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] M J Welch,et al. RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] A. Yokoyama,et al. Radiolabeled metabolites of proteins play a critical role in radioactivity elimination from the liver. , 1995, Nuclear medicine and biology.
[5] P. Cutler,et al. Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab')2. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] M. Welch,et al. Metabolism of receptor targeted 111In-DTPA-glycoproteins: identification of 111In-DTPA-epsilon-lysine as the primary metabolic and excretory product. , 1994, Nuclear medicine and biology.
[7] A. Yokoyama,et al. A biological method to evaluate bifunctional chelating agents to label antibodies with metallic radionuclides. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] K. Zinn,et al. Production of no‐carrier‐added 64Cu from zinc metal irradiated under boron shielding , 1994, Cancer.
[9] G. Denardo,et al. Comparative toxicity studies of yttrium‐90 mx‐dtpa and 2‐it‐bad conjugated monoclonal antibody (bre‐3) , 1994, Cancer.
[10] M. Welch,et al. Intracellular metabolism of indium-111-DTPA-labeled receptor targeted proteins. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] D. Kukis,et al. Selectivity of antibody-chelate conjugates for binding copper in the presence of competing metals , 1993 .
[12] T. Yokota,et al. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms. , 1993, Cancer research.
[13] M J Welch,et al. Copper-64-labeled antibodies for PET imaging. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] R. Reba,et al. Radiolabeled products in rat liver and serum after administration of antibody-amide-DTPA-indium-111. , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[15] M. Brechbiel,et al. Convenient synthesis of bifunctional tetraaza macrocycles. , 1992, Bioconjugate chemistry.
[16] A. Martell,et al. Stabilities of the alkaline earth and divalent transition metal complexes of the tetraazamacrocyclic tetraacetic acid ligands , 1991 .
[17] T. Kaden,et al. Antibody labeling with copper-67 using the bifunctional macrocycle 4-[(1,4,8,11-tetraazacyclotetradec-1-yl)methyl]benzoic acid. , 1991, Bioconjugate chemistry.
[18] S. Anderson,et al. Intracellular catabolism of radiolabeled anti-CD3 antibodies by leukemic T cells. , 1991, Cellular immunology.
[19] T. Waldmann,et al. Monoclonal antibodies in diagnosis and therapy , 1991, Science.
[20] A. Fischman,et al. Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] T. Visser,et al. In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats. , 1991, Life sciences.
[22] T. Rana,et al. N-terminal modification of immunoglobulin polypeptide chains tagged with isothiocyanato chelates. , 1990, Bioconjugate chemistry.
[23] D. Goldenberg,et al. Metabolism of indium-111-labeled murine monoclonal antibody in tumor and normal tissue of the athymic mouse. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] C. Meares,et al. Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane. , 1990, Bioconjugate chemistry.
[25] G. Denardo,et al. Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] G. Denardo,et al. Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] H. Sands,et al. Uptake and metabolism of 111In-labeled monoclonal antibody B6.2 by the rat liver. , 1990, Cancer research.
[28] C. Meares,et al. Bifunctional chelating agents for radiometal-labeled monoclonal antibodies. , 1990, Cancer treatment and research.
[29] C. Park,et al. Endocytosis and lysosomal hydrolysis of proteins in proximal tubules. , 1990, Methods in enzymology.
[30] N. LaRusso,et al. The liver and intracellular digestion: How liver cells eat! , 1989, Hepatology.
[31] J. Coppey,et al. Similar lethal effect in mammalian cells for two radioisotopes of copper with different decay schemes, 64Cu and 67Cu. , 1989, International journal of radiation biology.
[32] R. Wahl,et al. Studies on the metabolic fate of 111In-labeled antibodies. , 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[33] S. Denardo,et al. Chelate radiochemistry: Cleavable linkers lead to altered levels of radioactivity in the liver , 1988, International journal of cancer. Supplement = Journal international du cancer. Supplement.
[34] H. Sands,et al. Methods for the study of the metabolism of radiolabeled monoclonal antibodies by liver and tumor. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[35] T. Kaden,et al. Metal complexes with macrocyclic ligands. Part XXV. One‐step synthesis of mono‐N‐substituted azamacrocycles with a carboxylic group in the side‐chain and their complexes with Cu2+ and Ni2+ , 1986 .
[36] J. Lake,et al. Fluid phase endocytosis by cultured rat hepatocytes and perfused rat liver: implications for plasma membrane turnover and vesicular trafficking of fluid phase markers. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Denardo,et al. Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent. , 1985, Analytical biochemistry.
[38] C. Owen. Biochemical aspects of copper: copper proteins, ceruloplasmin, and copper protein binding. , 1982 .
[39] C. Duve,et al. Fate of plasma membrane during endocytosis. II. Evidence for recycling (shuttle) of plasma membrane constituents , 1979, The Journal of cell biology.
[40] A. Leo,et al. Substituent constants for correlation analysis in chemistry and biology , 1979 .
[41] A. Leo,et al. Substituent constants for correlation analysis. , 1977, Journal of medicinal chemistry.
[42] K. Kovács,et al. Properties of enzymes. II. Comparative study of superoxide dismutase activity in rat tissues. , 1975, Enzyme.
[43] D. Goldenberg,et al. GW-39: a new human tumor serially transplantable in the golden hamster. , 1966, Transplantation.
[44] W. Straus. CYTOCHEMICAL OBSERVATIONS ON THE RELATIONSHIP BETWEEN LYSOSOMES AND PHAGOSOMES IN KIDNEY AND LIVER BY COMBINED STAINING FOR ACID PHOSPHATASE AND INTRAVENOUSLY INJECTED HORSERADISH PEROXIDASE , 1964, The Journal of cell biology.
[45] J. Folch,et al. A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.